CVS has replaced its CEO, and is working to reassure investors. The stock has jumped more than 20% in the first weeks of 2025 ...
Diagnosed with asthma as a baby, Cole Schmidtknecht took the inhaler daily as a preventive medication since he was about 13, ...
EmblemHealth, one of the nation's largest not-for-profit health insurers, today announced the appointment of Dr. Daniel Knecht as its new Chief Medical Officer. As CMO, Dr. Knecht will lead the health ...
Across healthcare system, stakeholders share blame for high costs. This includes hospitals, drugmakers, insurers and others ...
CVS Health investors will closely examine this week turnaround initiatives spearheaded by new CEO David Joyner and their ...
Lawmakers determined to enact new restrictions on pharmacy benefit managers are trying to include legislation, which nearly passed in December, in a budget package that must pass by next month.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results